EXPRESS PHARMA: Exyte and Univercells Technologies to deploy vaccine production plants
The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the COVID-19 pandemic
EXPRESS PHARMA: Exyte and Univercells Technologies to deploy vaccine production plants
The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the COVID-19 pandemic